14 February 2023
Linesight is delighted to share the recording of its recent public webinar, where a panel of experts provided an overview of the Linesight Capital Project Benchmarking programme and high-level insights that have emerged from analysis of over 168 global projects valued at US$26 billion. The programme commenced in 2020 and has grown into a global collaboration of 17 leading pharmaceutical companies benchmarking and aligning cost and schedule data across capital projects.
To view the full recording, click here.
Share
Related News
15 February 2023
Linesight Q4 2022 Commodity Reports